Header Logo

Connection

Jamile Shammo to Mitoxantrone

Back to Details
This is a "connection" page, showing publications Jamile Shammo has written about Mitoxantrone.
Jamile Shammo
Connection Strength
0.025
Mitoxantrone
  1. Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma. Clin Lymphoma Myeloma Leuk. 2011 Dec; 11(6):467-74.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.